European Patent Office

T 1685/10 (RAS-inhibitors/ARK THERAPEUTICS LTD., ET AL) of 06.06.2011

European Case Law Identifier
ECLI:EP:BA:2011:T168510.20110606
Date of decision
6 June 2011
Case number
T 1685/10
Petition for review of
-
Application number
04021889.3
IPC class
A61K 31/44
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
The use of inhibitors of the renin-angiotensin system
Applicant name
Ark Therapeutics Limited, et al
Opponent name
LES LABORATOIRES SERVIER
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Merck & Co., Inc.
Sanofi-Aventis Deutschland GmbH
Board
3.3.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 83
Keywords
All requests: sufficiency of disclosure (no): insufficient tests
Catchword
-
Cited cases
T 0433/05

ORDER

For these reasons it is decided that:

The appeal is dismissed.